Obesity-related Complications
2 clinical trials · Condition
◉ Watch Obesity-related Complications
| Record | Firm | Date |
|---|---|---|
| Pre-approval Expanded Access of Retatrutide (LY3437943) (NCT07629401) | Eli Lilly and Company |
Track Obesity-related Complications automatically
Every clearance here is in the API, with alerts when new ones post.